NCT00225667View on ClinicalTrials.gov

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

PHASE3UnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

July 31, 2007

Conditions
Atrial FibrillationHypertension
Interventions
DRUG

Irbesartan

Trial Locations (1)

L8L 2X2

Population Health Research Institute of McMaster University, Hamilton

Sponsors
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Connolly, Stuart, M.D.

INDIV